S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
Become an Investor in Brooklyn Gin (Ad)pixel
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Is This The End of Capitalism? (Ad)
Cassava Sciences Stock Undervalued with Its $124 Price Target?
Why Extreme Networks is a Recession-Proof Technology Play
Hot craft spirits opportunity you don't want to miss (Ad)pixel
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
Grab Shares Are Suddenly On Track To Double
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
Become an Investor in Brooklyn Gin (Ad)pixel
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Is This The End of Capitalism? (Ad)
Cassava Sciences Stock Undervalued with Its $124 Price Target?
Why Extreme Networks is a Recession-Proof Technology Play
Hot craft spirits opportunity you don't want to miss (Ad)pixel
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
Grab Shares Are Suddenly On Track To Double
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
Become an Investor in Brooklyn Gin (Ad)pixel
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Is This The End of Capitalism? (Ad)
Cassava Sciences Stock Undervalued with Its $124 Price Target?
Why Extreme Networks is a Recession-Proof Technology Play
Hot craft spirits opportunity you don't want to miss (Ad)pixel
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
Grab Shares Are Suddenly On Track To Double
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
Become an Investor in Brooklyn Gin (Ad)pixel
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Is This The End of Capitalism? (Ad)
Cassava Sciences Stock Undervalued with Its $124 Price Target?
Why Extreme Networks is a Recession-Proof Technology Play
Hot craft spirits opportunity you don't want to miss (Ad)pixel
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
Grab Shares Are Suddenly On Track To Double
OTCMKTS:MSLP

MusclePharm - MSLP Stock Forecast, Price & News

$0.0013
0.00 (0.00%)
(As of 01/30/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.0013
$0.0013
50-Day Range
N/A
52-Week Range
$0.0002
$0.0002
Volume
N/A
Average Volume
26,442 shs
Market Capitalization
$43,407.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

MSLP stock logo

About MusclePharm (OTCMKTS:MSLP) Stock

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.

Receive MSLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MusclePharm and its competitors with MarketBeat's FREE daily newsletter.

MSLP Stock News Headlines

Why MusclePharm (MSLP) Stock Is Up Today
MusclePharm Announces the Launch of FitMiss Energy
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
MusclePharm Files For Uplisting IPO To Nasdaq
MusclePharm Announces First Quarter 2022...
Hot craft spirits opportunity you don't want to miss
Award winning products. Global distribution. New distillery. New products.pixel
MusclePharm releases preliminary Q421 results
MusclePharm teams up with Alliance Sales & Marketing
MusclePharm Announces Third Quarter 2021 Financial Results
See More Headlines
Receive MSLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MusclePharm and its competitors with MarketBeat's FREE daily newsletter.

MSLP Company Calendar

Last Earnings
8/10/2015
Today
1/30/2023
Next Earnings (Estimated)
3/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:MSLP
Fax
N/A
Employees
27
Year Founded
N/A

Profitability

Net Income
$-12,870,000.00
Pretax Margin
-38.52%

Debt

Sales & Book Value

Annual Sales
$50.04 million
Book Value
($0.94) per share

Miscellaneous

Free Float
13,121,000
Market Cap
$43,407.00
Optionable
Not Optionable
Beta
-0.07

Key Executives

  • Mr. Ryan Charles Drexler (Age 51)
    Exec. Chairman & CEO
    Comp: $1.64M
  • John Mills Mills
    Sr. Managing Director
  • Mr. Gary Charles Shirshac (Age 60)
    Interim Chief Financial Officer
  • Mr. Eric Chin (Age 42)
    Chief Accounting Officer & Director
  • Dr. Roscoe M. Moore Jr. (Age 77)
    DSc, DVM, MPH, Ph.D., Chief Scientific Director & Member of Scientific Advisory Board
  • Mr. Mark E. Groussman (Age 49)
    Consultant













MSLP Stock - Frequently Asked Questions

How have MSLP shares performed in 2023?

MusclePharm's stock was trading at $0.0007 at the beginning of the year. Since then, MSLP stock has increased by 85.7% and is now trading at $0.0013.
View the best growth stocks for 2023 here
.

When is MusclePharm's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 9th 2023.
View our MSLP earnings forecast
.

How were MusclePharm's earnings last quarter?

MusclePharm Co. (OTCMKTS:MSLP) released its quarterly earnings results on Monday, August, 10th. The company reported ($0.51) earnings per share for the quarter, missing analysts' consensus estimates of ($0.19) by $0.32. The company had revenue of $50.48 million for the quarter, compared to analysts' expectations of $55 million.

What other stocks do shareholders of MusclePharm own?
What is MusclePharm's stock symbol?

MusclePharm trades on the OTCMKTS under the ticker symbol "MSLP."

How do I buy shares of MusclePharm?

Shares of MSLP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MusclePharm's stock price today?

One share of MSLP stock can currently be purchased for approximately $0.00.

How much money does MusclePharm make?

MusclePharm (OTCMKTS:MSLP) has a market capitalization of $43,407.00 and generates $50.04 million in revenue each year. The company earns $-12,870,000.00 in net income (profit) each year or ($0.58) on an earnings per share basis.

How can I contact MusclePharm?

MusclePharm's mailing address is 4400 VANOWEN STREET, BURBANK CA, 80239. The official website for the company is www.musclepharm.com. The company can be reached via phone at (800) 292-3909 or via email at investors@musclepharm.com.

This page (OTCMKTS:MSLP) was last updated on 1/31/2023 by MarketBeat.com Staff